Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval ##### Up next ###### [PROCESSED RED MEAT RAISES THE RISK OF DEMENTIA; SWAPPING IT FOR NUTS AND BEANS MAY LOWER RISK](https://thailandbusinessnews.net/press-release/processed-red-meat-raises-the-risk-of-dementia-swapping-it-for-nuts-and-beans-may-lower-risk/) Published on 31 July 2024 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) SHENZHEN, China, July 31, 2024 /PRNewswire/ — On July 28 2024, Kexing Biopharm announced European Commission approval of Apexelsin®, the generic drug to Bristol Myers Squibb’s and Celgene’s Abraxane®(Nab-paclitaxel). Apexelsin® is developed by WhiteOak Pharmaceutical B.V. and Kexing Biopharm is in charge of the commercialization of this product out of US. Nanoparticle albumin-bound paclitaxel offers significant advantages for clinical use, providing improved safety and higher patient compliance, compared to solvent-based paclitaxel and liposomal paclitaxel. It is widely accepted in the clinical setting and holds crucial value in oncology. Furthermore, the European Society for Medical Oncology (ESMO) guidelines recommend it as a first-line treatment for metastatic pancreatic cancer and non-small cell lung cancer (NSCLC), as well as a second-line option for breast cancer. Breast cancer is one of the common cancer types in women in the EU region, and there is a large market space for breast cancer treatment drugs. In recent years, the Chinese pharmaceutical industry has embarked on a significant expansion into international markets. But actually, Kexing Biopharm began its international ventures 20 years ago with its core products. In recent years, the company has introduced more than a dozen high-quality Chinese medications to emerging markets, improving accessibility to medicines for local patients. The approval of albumin-bound paclitaxel by the EU will enhance the company’s competitiveness in the international pharmaceutical market. It also signifies that Kexing Biopharm, in addition to its long-established presence in emerging markets, is expanding its commercialization efforts into the European market. The EU market represents an important milestone in the company’s overseas commercialization strategy. To date, Kexing Biopharm is proceeding with the registration of Apexelsin® in dozens of emerging market out of Europe. With the successful launch of this product in the EU, Kexing Biopharm will further expand its global sales reach, serving more patients and healthcare providers. [Source link ](https://www.prnasia.com/story/archive/4473475_AE73475_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/clarivate-report-explores-opportunities-for-innovation-and-market-expansion-in-latin-america/) ![Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2025/02/Clarivate_Logo_v1.jpg?resize=260%2C140&ssl=1 "Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America New insights from Clarivate examine strategic partnerships, API production, and innovation in… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - February 27, 2025 [](https://thailandbusinessnews.net/press-release/fair-play-menarini-international-award-the-2025-edition-begins-with-the-announcement-of-this-years-awardees-at-coni/) ![FAIR PLAY MENARINI INTERNATIONAL AWARD, THE 2025 EDITION BEGINS WITH THE ANNOUNCEMENT OF THIS YEAR'S AWARDEES AT CONI](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2025/06/Menarini_1.jpg?resize=260%2C140&ssl=1 "FAIR PLAY MENARINI INTERNATIONAL AWARD, THE 2025 EDITION BEGINS WITH THE ANNOUNCEMENT OF THIS YEAR'S AWARDEES AT CONI") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## FAIR PLAY MENARINI INTERNATIONAL AWARD, THE 2025 EDITION BEGINS WITH THE ANNOUNCEMENT OF THIS YEAR'S AWARDEES AT CONI ROME, June 11, 2025 /PRNewswire/ — The sense of anticipation is increasing,… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - June 11, 2025 [](https://thailandbusinessnews.net/press-release/new-content-map-event-time-limited-gacha-and-time-limited-shop-items-added/) ![[New Content] Map Event, Time-Limited Gacha, and Time-Limited Shop items added](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2024/02/1707963360_image_1.jpg?resize=260%2C140&ssl=1 "[New Content] Map Event, Time-Limited Gacha, and Time-Limited Shop items added") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## \[New Content\] Map Event, Time-Limited Gacha, and Time-Limited Shop items added TOKYO, Feb. 15, 2024 /PRNewswire/ — Infini-Brain’s Taimanin RPG Extasy has implemented… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - February 15, 2024 ##### Most Read - [![CMC REIT Steadily Advances Strategic Transformation in 2026 Interim Results](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/cmc-reit-steadily-advances-strategic-transformation-in-2026-interim-results/ "CMC REIT Steadily Advances Strategic Transformation in 2026 Interim Results") [CMC REIT Steadily Advances Strategic Transformation in 2026 Interim Results](https://thailandbusinessnews.net/press-release/cmc-reit-steadily-advances-strategic-transformation-in-2026-interim-results/ "CMC REIT Steadily Advances Strategic Transformation in 2026 Interim Results") - [![UOB Poll Finds SMEs Keen on AI but Struggle to Move Beyond Pilot Stage](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/uob-poll-finds-smes-keen-on-ai-but-struggle-to-move-beyond-pilot-stage/ "UOB Poll Finds SMEs Keen on AI but Struggle to Move Beyond Pilot Stage") [UOB Poll Finds SMEs Keen on AI but Struggle to Move Beyond Pilot Stage](https://thailandbusinessnews.net/press-release/uob-poll-finds-smes-keen-on-ai-but-struggle-to-move-beyond-pilot-stage/ "UOB Poll Finds SMEs Keen on AI but Struggle to Move Beyond Pilot Stage") - [![Joget Introduces Agent Lab, a Program Helping Businesses Build AI Agents Without Code](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/joget-introduces-agent-lab-a-program-helping-businesses-build-ai-agents-without-code/ "Joget Introduces Agent Lab, a Program Helping Businesses Build AI Agents Without Code") [Joget Introduces Agent Lab, a Program Helping Businesses Build AI Agents Without Code](https://thailandbusinessnews.net/press-release/joget-introduces-agent-lab-a-program-helping-businesses-build-ai-agents-without-code/ "Joget Introduces Agent Lab, a Program Helping Businesses Build AI Agents Without Code") - [![Russell Reynolds Associates Announces Nick Fletcher as Australia Country Leader](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/russell-reynolds-associates-announces-nick-fletcher-as-australia-country-leader/ "Russell Reynolds Associates Announces Nick Fletcher as Australia Country Leader") [Russell Reynolds Associates Announces Nick Fletcher as Australia Country Leader](https://thailandbusinessnews.net/press-release/russell-reynolds-associates-announces-nick-fletcher-as-australia-country-leader/ "Russell Reynolds Associates Announces Nick Fletcher as Australia Country Leader") - [![Hyundai Motor Company Charts Profit-Driven Growth Roadmap at 2026 CEO Investor Day](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/hyundai-motor-company-charts-profit-driven-growth-roadmap-at-2026-ceo-investor-day/ "Hyundai Motor Company Charts Profit-Driven Growth Roadmap at 2026 CEO Investor Day") [Hyundai Motor Company Charts Profit-Driven Growth Roadmap at 2026 CEO Investor Day](https://thailandbusinessnews.net/press-release/hyundai-motor-company-charts-profit-driven-growth-roadmap-at-2026-ceo-investor-day/ "Hyundai Motor Company Charts Profit-Driven Growth Roadmap at 2026 CEO Investor Day") - [![Voltage Energy Will Seek New Trial and Review of Verdict in Shoals Patent Dispute](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/voltage-energy-will-seek-new-trial-and-review-of-verdict-in-shoals-patent-dispute/ "Voltage Energy Will Seek New Trial and Review of Verdict in Shoals Patent Dispute") [Voltage Energy Will Seek New Trial and Review of Verdict in Shoals Patent Dispute](https://thailandbusinessnews.net/press-release/voltage-energy-will-seek-new-trial-and-review-of-verdict-in-shoals-patent-dispute/ "Voltage Energy Will Seek New Trial and Review of Verdict in Shoals Patent Dispute") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/kazia-therapeutics-limited-announces-proposed-public-offering/) ## Kazia Therapeutics Limited Announces Proposed Public Offering SYDNEY, Aug. 28, 2026 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ:… [](https://thailandbusinessnews.net/press-release/kazia-therapeutics-reports-100-clinical-benefit-rate-in-initial-six-patients-treated-for-advanced-triple-negative-breast-cancer/) ## Kazia Therapeutics Reports 100% Clinical Benefit Rate in Initial Six Patients Treated for Advanced Triple-Negative Breast Cancer Durable Complete Metabolic Response Ongoing Since November 2025 All Evaluable Patients… [](https://thailandbusinessnews.net/press-release/global-genomics-and-multi-omics-leader-novogene-to-establish-its-first-australian-laboratory-at-cabrini-health-accelerating-access-to-precision-cancer-care/) ![Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care](https://i0.wp.com/mmx.prnasia.com/media/MS1976829/20260827035513EDT_image_1.jpg?resize=260%2C140&ssl=1 "Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care") ## Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care MELBOURNE, Australia, Aug. 28, 2026 /PRNewswire/ — Global multi-omics leader… [](https://thailandbusinessnews.net/press-release/tutti-vm-launches-in-early-access-the-google-docs-moment-for-cross-agent-collaboration/) ![Tutti • VM Launches in Early Access: The Google Docs Moment for Cross-Agent Collaboration](https://i0.wp.com/mmx.prnasia.com/media/MS1973504/20260821015411EDT_image_3.jpg?resize=260%2C140&ssl=1 "Tutti • VM Launches in Early Access: The Google Docs Moment for Cross-Agent Collaboration") ## Tutti • VM Launches in Early Access: The Google Docs Moment for Cross-Agent Collaboration Local agents stay local and identity never leaves the machine, while multi-layer…